OC
PFE icon

Oppenheimer & Close’s Pfizer PFE Stock Holding History

Oppenheimer & Close’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-93,880
Closed -$2.28M – 59
2025
Q2 		$2.28M Sell
93,880
-5,675
-6% -$132K 1.74% 21
2025
Q1 		$2.52M Sell
99,555
-5,755
-5% -$151K 2.08% 19
2024
Q4 		$2.79M Sell
105,310
-7,025
-6% -$191K 2.3% 16
2024
Q3 		$3.25M Sell
112,335
-25,125
-18% -$733K 2.61% 15
2024
Q2 		$3.85M Sell
137,460
-7,400
-5% -$204K 3.38% 11
2024
Q1 		$4.02M Buy
144,860
+500
+0.3% +$13.9K 3.49% 9
2023
Q4 		$4.16M Buy
144,360
+5,285
+4% +$160K 3.79% 8
2023
Q3 		$4.61M Buy
139,075
+2,470
+2% +$87.3K 4.6% 6
2023
Q2 		$5.01M Sell
136,605
-5,266
-4% -$205K 5.2% 4
2023
Q1 		$5.79M Sell
141,871
-720
-0.5% -$31.1K 5.73% 3
2022
Q4 		$7.31M Sell
142,591
-1,635
-1% -$78.4K 7.18% 1
2022
Q3 		$6.31M Buy
144,226
+1,645
+1% +$79.9K 6.83% 2
2022
Q2 		$7.47M Sell
142,581
-7,445
-5% -$379K 8.53% 2
2022
Q1 		$7.77M Buy
150,026
+2,270
+2% +$118K 6.7% 3
2021
Q4 		$8.72M Sell
147,756
-3,364
-2% -$167K 8.21% 2
2021
Q3 		$6.5M Sell
151,120
-7,020
-4% -$311K 6.23% 3
2021
Q2 		$6.19M Buy
+158,140
New +$6.15M 5.74% 4
2015
Q4 		– Sell
-125,863
Closed -$3.75M – 53
2015
Q3 		$3.75M Buy
125,863
+1,634
+1% +$52.4K 3.19% 12
2015
Q2 		$3.95M Sell
124,229
-1,528
-1% -$49.8K 3.29% 12
2015
Q1 		$4.15M Hold
125,757
– – 3.5% 11
2014
Q4 		$3.72M Sell
125,757
-158
-0.1% -$4.53K 3.12% 13
2014
Q3 		$3.53M Sell
125,915
-1,054
-0.8% -$29.6K 2.9% 13
2014
Q2 		$3.58M Sell
126,969
-408
-0.3% -$11.6K 2.88% 12
2014
Q1 		$3.88M Sell
127,377
-3,619
-3% -$108K 3.24% 11
2013
Q4 		$3.81M Sell
130,996
-3,548
-3% -$103K 3.29% 11
2013
Q3 		$3.67M Buy
134,544
+13,481
+11% +$367K 2.61% 13
2013
Q2 		$3.22M Buy
+121,063
New +$3.34M 2.37% 13

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Oppenheimer & Close's PFE Position: Q3 2025 in Review

Oppenheimer & Close sold out of Pfizer (PFE) in Q3 2025, closing a stake of 93,880 shares — an estimated $2.28M sold.

Oppenheimer & Close first reported a position in PFE in Q2 2013 and held it in 27 quarters. The position peaked at $8.72M in Q4 2021. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Oppenheimer & Close reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Oppenheimer & Close sold 93,880 Pfizer shares in Q3 2025, an estimated $2.28M.
  • Oppenheimer & Close first reported a position in Pfizer in Q2 2013 and held it in 27 quarters.
  • Oppenheimer & Close's Pfizer position peaked at $8.72M in Q4 2021.
  • 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Oppenheimer & Close's 13F filing for Q3 2025, filed 10 Nov 2025.